[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zhao et al., 2019 - Google Patents

Circular RNAs: biogenesis, mechanism, and function in human cancers

Zhao et al., 2019

View HTML
Document ID
7178306499777930523
Author
Zhao X
Cai Y
Xu J
Publication year
Publication venue
International journal of molecular sciences

External Links

Snippet

CircRNAs are a class of noncoding RNA species with a circular configuration that is formed by either typical spliceosome-mediated or lariat-type splicing. The expression of circRNAs is usually abnormal in many cancers. Several circRNAs have been demonstrated to play …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.

Similar Documents

Publication Publication Date Title
Zhao et al. Circular RNAs: biogenesis, mechanism, and function in human cancers
Chan et al. Noncoding RNA: RNA regulatory networks in cancer
Xu et al. New insights into the interplay between non-coding RNAs and RNA-binding protein HnRNPK in regulating cellular functions
Yu et al. Circulating microRNAs: potential biomarkers for cancer
Qin et al. Transcription factor and miRNA interplays can manifest the survival of ccRCC patients
Fang et al. MicroRNA-223-3p regulates ovarian cancer cell proliferation and invasion by targeting SOX11 expression
Ouyang et al. Deep sequencing analysis of miRNA expression in breast muscle of fast-growing and slow-growing broilers
Morita et al. Genome-wide analysis of DNA methylation and expression of microRNAs in breast cancer cells
Caba et al. Circular RNA—Is the Circle Perfect?
Meng et al. Circular RNA as a novel biomarker and therapeutic target for HCC
Kumar et al. MiR-375 regulation of LDHB plays distinct roles in polyomavirus-positive and-negative Merkel cell carcinoma
Das et al. Rolling circle cDNA synthesis uncovers circular RNA splice variants
Koenig et al. A comprehensive analysis of argonaute-CLIP data identifies novel, conserved and species-specific targets of miR-21 in human liver and hepatocellular carcinoma
Wen et al. Microarray expression profiling of long non-coding RNAs involved in nasopharyngeal carcinoma metastasis
Cristóbal et al. The role of microRNAs in hepatoblastoma tumors
van den Homberg et al. N-6-Methyladenosine in vasoactive microRNAs during hypoxia; a novel role for METTL4
Jaafar et al. 2′ O-ribose methylation of ribosomal RNAs: natural diversity in living organisms, biological processes, and diseases
Lee et al. Hypoxia promotes vascular smooth muscle cell proliferation through microRNA-mediated suppression of cyclin-dependent kinase inhibitors
Cristóbal et al. Functional and clinical impact of CircRNAs in oral cancer
Wu et al. Effect of humantenine on mRNA m6A modification and expression in human colon cancer cell line HCT116
Tian et al. Comparative analysis of microRNA binding site distribution and microRNA-mediated gene expression repression of oncogenes and tumor suppressor genes
Jia et al. Altered miRNA and mRNA expression in sika deer skeletal muscle with age
Lyu et al. Chi-miR-487b-3p inhibits goat myoblast proliferation and differentiation by targeting IRS1 through the IRS1/PI3K/Akt signaling pathway
Nedoluzhko et al. The biomarker and therapeutic potential of circular Rnas in Schizophrenia
Mei et al. Emerging mutual regulatory roles between m6A modification and microRNAs